Le récepteur de la gastrine active la voie JAK2/STAT3 dans des modèles tumoraux pancréatiques
Audrey Ferrand(Université Toulouse III - Paul Sabatier), Catherine Seva(Inserm), Lucien Pradayrol(Inserm), Dominique Fourmy, Aline Kowalski‐Chauvel(Université Toulouse III - Paul Sabatier), André Mathieu(Inserm), M. Dufresne(Inserm), C. Bertrand(Inserm), Chantal Escrieut(Inserm)
Cited by 0
Related Papers
Epidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib
|Cancer Research|2007|192
Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
|Frontiers in Cell and Developmental Biology|2020|154
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
|Leukemia|2005|139
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis
|Proceedings of the National Academy of Sciences|2002|124
Gastrin and cancer: A review
|Cancer Letters|2005|119